-
1
Unconventional Nuclides for Radiopharmaceuticals
Published 2010-01-01“…Rapid and widespread growth in the use of nuclear medicine for both diagnosis and therapy of disease has been the driving force behind burgeoning research interests in the design of novel radiopharmaceuticals. Until recently, the majority of clinical and basic science research has focused on the development of 11 C-, 13 N-, 15 O-, and 18 F-radiopharmaceuticals for use with positron emission tomography (PET) and 99m Tc-labeled agents for use with single-photon emission computed tomography (SPECT). …”
Get full text
Article -
2
-
3
-
4
Tryptophan Kynurenine Pathway-Based Imaging Agents for Brain Disorders and Oncology—From Bench to Bedside
Published 2025-01-01Subjects: Get full text
Article -
5
Radiopharmacokinetic modelling and radiation dose assessment of 223Ra used for treatment of metastatic castration-resistant prostate cancer
Published 2021-06-01Subjects: “…Radiopharmaceutical…”
Get full text
Article -
6
Currents status of radiotracers for breast cancer imaging in PET
Published 2025-03-01Subjects: Get full text
Article -
7
-
8
-
9
RevCAR-mediated T-cell response against PD-L1-expressing cells turns suppression into activation
Published 2025-02-01Get full text
Article -
10
-
11
-
12
Development of an automated method for in-house production of sodium 18F-fluoride for injection: process validation as a step toward routine clinical application
Published 2025-02-01“…Process validation was carried according to GMP guidelines to ensure consistency of [18F]NaF quality with international standards. The final radiopharmaceutical met all quality criteria specified by Ph. …”
Get full text
Article -
13
-
14
New Therapeutics to Treat Castrate-Resistant Prostate Cancer
Published 2013-01-01“…In this review, we will examine mechanistic and clinical data of several newly approved therapeutics including the chemotherapeutic cabazitaxel, antiandrogen enzalutamide, endocrine disruptor abiraterone acetate, immunotherapy sipuleucel-T, and bone-targeting radiopharmaceutical alpharadin. In addition, we will examine other promising therapeutics that are currently in Phase III trials.…”
Get full text
Article -
15
Imaging in Periprosthetic Joint Infection Diagnosis: A Comprehensive Review
Published 2024-12-01“…Each imaging technique and radiopharmaceutical has been extensively studied, with unique diagnostic accuracy, limitations, and benefits for PJI diagnosis. …”
Get full text
Article -
16
Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms
Published 2013-01-01“…While several radiopharmaceuticals were approved for pain palliation in mCRPC including strontium and samarium, alpharadin is the first radiopharmaceutical to show significant overall survival benefit. …”
Get full text
Article -
17
Folate Receptor–Targeted Single-Photon Emission Computed Tomography/Computed Tomography to Detect Activated Macrophages in Atherosclerosis: Can It Distinguish Vulnerable from Stabl...
Published 2014-01-01“…We investigated the feasibility of a folate-based radiopharmaceutical ( 111 In-EC0800) with high-resolution animal single-photon emission computed tomography/computed tomography (SPECT/CT) to differentiate between stable and vulnerable atherosclerotic plaques in apolipoprotein E 7 mice in which we can induce plaques with the characteristics of stable and vulnerable plaques by placing a flow-modifying cast around the common carotid artery. …”
Get full text
Article -
18
Comparative Experiment on the Preparation of 99Mo/99mTc via Electron and Proton Irradiation of 100Mo
Published 2025-02-01“…99mTc derived from 99Mo,stands as the preeminent radiopharmaceutical employed extensively in medical diagnostics worldwide. …”
Get full text
Article -
19
Quality of computed tomography image versus dose in hybrid studies: preliminary results in phantom
Published 2022-03-01“…<p><strong>Background:</strong> hybrid studies produce a total radiation dose that is the result of the dose imparted by the radiopharmaceutical and that emitted by the computed tomography, therefore optimization is essential.…”
Get full text
Article -
20
Emerging Role of PET in the Diagnosis and Staging of Lung Cancer
Published 1999-01-01“…Malignant tumours demonstrate increased uptake of FDG, a positron-emitting radiopharmaceutical. This increased FDG uptake in tumours can be seen using PET. …”
Get full text
Article